Isopedicin effectively and concentration-dependently inhibits superoxide anion (O₂•⁻) production in formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP)-activated cells; it increases cAMP formation and PKA activity in FMLP-activated cells by inhibiting phosphodiesterase (PDE) activity.